Valuation Beijing Beilu Pharmaceutical Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 12/11/2026			5-day change	1st Jan Change
8.110 ^CNY	+0.12%		-1.10%	+2.14%

10-27	Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
09-20	Beijing Beilu Pharmaceutical Co., Ltd.(XSEC:300016) added to S&P Global BMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	4,727	4,523	3,208	3,503	3,050	4,469
Change	-	-4.32%	-29.09%	9.2%	-12.92%	46.53%
Enterprise Value (EV) ¹	4,417	4,204	3,088	3,545	3,239	4,300
Change	-	-4.82%	-26.55%	14.81%	-8.63%	32.77%
P/E	26.6x	36.7x	326x	-47.5x	207x	44.1x
PBR	2.71x	2.44x	1.81x	2.12x	1.83x	1.98x
PEG	-	-1.2x	-3.5x	0x	-2x	0x
Capitalization / Revenue	5.71x	5.36x	4.19x	3.93x	3.1x	3.71x
EV / Revenue	5.34x	4.98x	4.03x	3.98x	3.29x	3.57x
EV / EBITDA	24.6x	24.2x	44.7x	150x	22.6x	23.5x
EV / EBIT	32.2x	37.7x	-603x	-62.4x	60.8x	48.9x
EV / FCF	-1,039x	-34.3x	-52.9x	-20.1x	-134x	-25.5x
FCF Yield	-0.1%	-2.92%	-1.89%	-4.97%	-0.75%	-3.93%
Dividend per Share ²	0.06	0.07	0.07	-	0.05	-
Rate of return	0.63%	0.76%	1.07%	-	0.81%	-
EPS ²	0.36	0.25	0.02	-0.15	0.03	0.18
Distribution rate	16.7%	28%	350%	-	167%	-
Net sales ¹	827.3	843.9	765.9	890.7	983.6	1,205
EBITDA ¹	179.7	173.6	69.09	23.6	143.4	182.7
EBIT ¹	137.3	111.4	-5.124	-56.82	53.24	87.86
Net income ¹	174.7	125	11.21	-71.76	13.65	92.73
Net Debt ¹	-310.6	-319.3	-120	42.28	189.1	-168.8
Reference price ²	9.560	9.180	6.520	7.120	6.200	7.940
Nbr of stocks (in thousands)	494,494	492,718	491,956	491,935	491,935	562,873
Announcement Date	18/03/21	29/03/22	23/04/23	21/04/24	17/04/25	21/04/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
BEIJING BEILU PHARMACEUTICAL CO., LTD.	-	-	-	-	707M
ELI LILLY AND COMPANY	42.06x	14.21x	30.18x	0.47%	1,271B
JOHNSON & JOHNSON	41.04x	6.89x	19.37x	1.9%	683B
ABBVIE INC.	37.61x	8.63x	17.8x	2.34%	520B
ROCHE HOLDING AG	21.6x	5.24x	13.13x	2.49%	389B
MERCK & CO., INC.	104.47x	5.96x	25.4x	2.31%	362B
NOVARTIS AG	24.13x	5.85x	14.24x	2.72%	304B
ASTRAZENECA PLC	24.1x	4.84x	13.6x	1.8%	286B
AMGEN INC.	24.17x	7.41x	13.62x	2.16%	253B
GILEAD SCIENCES, INC.	-39.46x	7.31x	46.04x	1.97%	208B
Average	31.08x	7.37x	21.49x	2.02%	428B
Weighted average by Cap.	37.28x	8.89x	22.55x	1.69%